Early Screening For Type 2 Diabetes Cost Effective

According to a study published online March 30 in The Lancet, early screening for type 2 diabetes is cost effective and prevents diabetes-related complications, including myocardial infarction and blindness.

By using mathematical modeling to assess several screening strategies, researchers determined the most cost-effective approach is to begin screening patients for type 2 diabetes between ages 30 and 45, with follow-up every three to five years. They arrived at this conclusion by studying a simulated population of 325,000 non-diabetic 30-year-olds using the National Health and Nutrition Examination Survey data from 1999 through 2004.

Posted in: Diabetes mellitus